Daily News Podcast

Ezetimibe effective as primary prevention


 

Ezetimibe is found to be effective in lowering LDL for primary cardiovascular prevention in patients who were 75 or older. Also today, the FDA says that the benefits of paclitaxel-coated devices outweigh risks for peripheral arterial disease, flu activity is down for the second consecutive week, and a look at homelessness among LGBT youth in the United States.

Amazon Alexa

Apple Podcasts

Google Podcasts

Spotify

Recommended Reading

Healthcare.gov activity surged in last week of open enrollment
MDedge Infectious Disease
ICYMI: EP 01 Lorenzo Norris
MDedge Infectious Disease
EHRs and Burnout
MDedge Infectious Disease
Raymond Barfield Part I
MDedge Infectious Disease
Cerebral small vessel and cognitive impairment
MDedge Infectious Disease
Prenatal valproate and ADHD
MDedge Infectious Disease
AAP guidance: How to ask about military service
MDedge Infectious Disease
Think outside lower body for pelvic pain
MDedge Infectious Disease
Deep sleep decreases, Alzheimer’s increases
MDedge Infectious Disease
Cyberbullied by anti-vaxxers: Monique Tello Part I
MDedge Infectious Disease